Algorae Pharmaceuticals Limited (ASX:1AI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0120
0.00 (0.00%)
Aug 5, 2026, 3:24 PM AEST

Algorae Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
----00.27
Revenue Growth
-----98.73%-51.56%
Gross Profit
----00.27
Operating Income
-1.44-1.07-1.7-1.52-1.46-1.34
Net Income
-1.01-0.8-2.1-2.11-1.96-1.46
Earnings Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
1.882.323.114.114.241.61
Total Debt
------
Net Cash (Debt)
1.882.323.114.114.241.61
Net Cash Growth
-18.80%-25.39%-24.39%-3.02%162.92%-40.51%
Net Cash Per Share
0.000.000.000.000.000.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-0.7-0.79-1.52-1.99-2.04-1.46
Capital Expenditures
-----0-
Free Cash Flow
-0.7-0.79-1.52-1.99-2.05-1.46
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
----100.00%100.00%
Operating Margin
-----42870.16%-500.05%
Pretax Margin
-----69663.11%-710.50%
Profit Margin
-----57483.11%-544.62%
FCF Margin
-----60088.31%-544.97%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
----3019.5725.57